2021
DOI: 10.1096/fj.202100823r
|View full text |Cite
|
Sign up to set email alerts
|

Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation

Abstract: This is an open access article under the terms of the Creat ive Commo ns Attri butio n-NonCo mmerc ial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…Muscular hypotonia is highly prevalent (51–98%) and may lead to long-term sequelae including developmental delays and oromotor dysfunction [ 66 ]. Emerging evidence suggests that hypotonia may be due to a primary defect in skeletal muscle [ 67 ]. Dysarthria is not uncommon (10–26%) and may be underestimated [ 68 ].…”
Section: Resultsmentioning
confidence: 99%
“…Muscular hypotonia is highly prevalent (51–98%) and may lead to long-term sequelae including developmental delays and oromotor dysfunction [ 66 ]. Emerging evidence suggests that hypotonia may be due to a primary defect in skeletal muscle [ 67 ]. Dysarthria is not uncommon (10–26%) and may be underestimated [ 68 ].…”
Section: Resultsmentioning
confidence: 99%
“…Kmt2d is expressed in the developing mouse calvarial osteoblasts, epithelia, and neural tissues [40]. Moreover, the heterozygous loss of Kmt2d impairs the neuromuscular junction, muscle cell differentiation, and myofiber regeneration [2]. In addition, a growing body of research indicates that defects in neural crest development are a major cause of KS [41,42].…”
Section: Discussionmentioning
confidence: 99%
“…Kabuki syndrome (KS) is a rare genetic disorder caused by mutations in the histone modifier genes encoding histone H3 lysine 4 methyltransferase (KMT2D) and histone H3 lysine 27 demethylase (KDM6A) (OMIM: #147920 and #300867) [1,2]. The main clinical manifestations of KS include dysmorphic facial features, skeletal abnormalities, intellectual disability, hearing loss, and retarded postnatal growth.…”
Section: Introductionmentioning
confidence: 99%
“…Histone methyltransferase complexes are widely involved in the regulation of muscle development [ 75 , 76 ]. Mutations in KDM6A and KMT2D can reduce myocyte differentiation in vitro and damage muscle fiber regeneration in vivo [ 77 ].…”
Section: Discussionmentioning
confidence: 99%